These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 21319951

  • 1. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma.
    Lai CW, Chen KY, Hung CS, Kuo SW, Chang YJ, Lin MT, Chang KC, Wu MH.
    Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951
    [Abstract] [Full Text] [Related]

  • 2. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM, Lo CY, Lam AK, Leung P, Luk JM.
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
    Yu XM, Lo CY, Chan WF, Lam KY, Leung P, Luk JM.
    Clin Cancer Res; 2005 Nov 15; 11(22):8063-9. PubMed ID: 16299237
    [Abstract] [Full Text] [Related]

  • 4. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
    Jiang HG, Gao M, Tang WP, Li FH, Cai QZ.
    Ai Zheng; 2005 Sep 15; 24(9):1136-9. PubMed ID: 16159441
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nitric oxide in papillary thyroid carcinoma: induction of vascular endothelial growth factor D and correlation with lymph node metastasis.
    Nakamura Y, Yasuoka H, Zuo H, Takamura Y, Miyauchi A, Nakamura M, Kakudo K.
    J Clin Endocrinol Metab; 2006 Apr 15; 91(4):1582-5. PubMed ID: 16418215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuropilin-2 expression in papillary thyroid carcinoma: correlation with VEGF-D expression, lymph node metastasis, and VEGF-D-induced aggressive cancer cell phenotype.
    Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Inagaki M, Sanke T, Nakamura Y.
    J Clin Endocrinol Metab; 2011 Nov 15; 96(11):E1857-61. PubMed ID: 21880798
    [Abstract] [Full Text] [Related]

  • 10. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
    Tamura M, Ohta Y.
    Cancer; 2003 Sep 15; 98(6):1217-22. PubMed ID: 12973845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. VEGF-C and COX-2 expression in papillary thyroid cancer.
    Siironen P, Ristimäki A, Narko K, Nordling S, Louhimo J, Andersson S, Haapiainen R, Haglund C.
    Endocr Relat Cancer; 2006 Jun 15; 13(2):465-73. PubMed ID: 16728574
    [Abstract] [Full Text] [Related]

  • 14. [Expression of VEGF-C and angiogenesis, and lymphangiogenesis in papillary thyroid carcinoma].
    Liang QC, Wei QY, Fan SQ.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun 15; 31(3):414-6, 419. PubMed ID: 16859137
    [Abstract] [Full Text] [Related]

  • 15. VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients.
    Lai CW, Duh QY, Chen CW, Chuang FJ, Chang YJ, Lin MT, Wu MH.
    World J Surg; 2015 Jul 15; 39(7):1742-9. PubMed ID: 25670042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells.
    Scarpino S, Di Napoli A, Melotti F, Talerico C, Cancrini A, Ruco L.
    J Pathol; 2007 Aug 15; 212(4):411-9. PubMed ID: 17573672
    [Abstract] [Full Text] [Related]

  • 18. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma.
    Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S.
    Clin Cancer Res; 2000 Jun 15; 6(6):2431-9. PubMed ID: 10873096
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.